Literature DB >> 10353636

Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities.

R Ando1, T Sakaki, Y Morinaka, C Takahashi, Y Tamao, N Yoshii, S Katayama, K Saito, H Tokuyama, M Isaka, E Nakamura.   

Abstract

By focusing on the amphiphilic properties of cyclopropenone (e.g. a good electrophile and a precursor for a stable 2pi-aromatic hydroxycyclopropenium cation), a new class of cysteine proteinase inhibitors containing a cyclopropenone moiety was designed. For the purpose of the present research, we needed to devise a new method to introduce a peptide-related moiety as a substituent on the cyclopropenone residue. We investigated the reaction of metalated cyclopropenone acetal derivatives (2, R2 = metal) with N-protected alpha-aminoaldehydes 4 to obtain the adduct 5, and succeeded in the preparation of highly potentiated cysteine proteinase inhibitors 8 after several steps transformations. They showed strong inhibitory activities only to cysteine proteinases such as calpain, papain, cathepsin B, and cathepsin L and not to serine (e.g. thrombin and cathepsin G) and aspartic proteinases (e.g. cathepsin D). Kinetic studies indicated that they are competitive inhibitors, and by the examinations of their inhibitory mechanism it became clear that they are reversible inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353636     DOI: 10.1016/s0968-0896(99)00007-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  BDA-410 Treatment Reduces Body Weight and Fat Content by Enhancing Lipolysis in Sedentary Senescent Mice.

Authors:  Andrea S Pereyra; Zhong-Min Wang; Maria Laura Messi; Tan Zhang; Hanzhi Wu; Thomas C Register; Elizabeth Forbes; Nelmi O Devarie-Baez; Daniel Clark Files; Martin C Abba; Cristina Furdui; Osvaldo Delbono
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-08-01       Impact factor: 6.053

2.  Peptidyl cyclopropenones: reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases?

Authors:  Meital Cohen; Uriel Bretler; Amnon Albeck
Journal:  Protein Sci       Date:  2013-04-29       Impact factor: 6.725

Review 3.  Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.

Authors:  Marton Siklos; Manel BenAissa; Gregory R J Thatcher
Journal:  Acta Pharm Sin B       Date:  2015-09-26       Impact factor: 11.413

4.  Discovery of a Novel Aminocyclopropenone Compound That Inhibits BRD4-Driven Nucleoporin NUP210 Expression and Attenuates Colorectal Cancer Growth.

Authors:  Hiroya Kondo; Kenji Mishiro; Yuki Iwashima; Yujia Qiu; Akiko Kobayashi; Keesiang Lim; Takahiro Domoto; Toshinari Minamoto; Kazuma Ogawa; Munetaka Kunishima; Masaharu Hazawa; Richard W Wong
Journal:  Cells       Date:  2022-01-18       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.